AEM vs ITRG

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

ITRG presents a stark contrast between a weak deterministic health profile (Piotroski F-Score: 2/9) and an aggressive growth trajectory. While the company has historically struggled with consistent earnings misses and negative net income, recent data shows a critical pivot toward profitability with a Forward P/E of 3.35 and explosive YoY revenue growth of 81.70%. The balance sheet is lean with very low debt (D/E 0.12) and strong liquidity, but the bearish technical trend and poor historical health score necessitate a cautious approach despite the bullish analyst target of $6.50.